Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $351.06 | $19.23 | 1,725.53% | 7,021.20x | 105.23x | 7.78x | 9.42x | 6.78x | $529.27M | 1.37% | $4.13B | 37.48 | $36.75B | 115.57 | ||
| NVO | NOVO NORDISK A S | $59.64 | $148.58 | -59.86% | 16.59x | 2.59x | 5.45x | 10.12x | 0.17x | $9.34B | 3.52% | $26.18B | 5.89 | $275.66B | 11.11 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $369.96 | $36.70 | 908.19% | 1,193.42x | 53.16x | 15.15x | 208.97x | 3.88x | $221.36M | 0.46% | $233.89M | 1.78 | $50.60B | 333.06 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $38.60 | $17.31 | 122.97% | 78.78x | 22.43x | 4.82x | 5.46x | 0.97x | $101.73M | 3.53% | $535.38M | 7.17 | $2.76B | 51.53 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.92 | $16.40 | -45.61% | 18.58x | 15.68x | 5.92x | 3.77x | 0.24x | -$23.64M | -4.74% | $133.17M | 2.38 | $510.45M | 7.60 | ||
| CORT | CORCEPT THERAPEUTICS INC | $36.35 | $43.04 | -15.54% | 36.35x | 33.08x | 5.08x | 6.05x | 0.36x | $162.57M | 4.32% | $631.90M | 6.10 | $3.70B | 56.15 | ||
| ARGX | ARGENX SE | $810.51 | $361.56 | 124.17% | 32.39x | 27.46x | 26,145.48x | 6.90x | 1.36x | $467.72M | 0.95% | $7.17B | 117.50 | $47.07B | 58.01 | ||
| VCEL | VERICEL CORP | $37.05 | $9.53 | 288.90% | 142.50x | 63.73x | 7.23x | 5.82x | 1.69x | $20.38M | 1.09% | $321.86M | 6.38 | $1.87B | 63.85 | ||
| KRYS | KRYSTAL BIOTECH INC | $291.93 | $115.60 | 152.53% | 42.31x | 36.38x | 22.65x | 7.44x | 1.41x | $166.02M | 1.96% | $1.14B | 39.30 | $8.08B | 41.81 | ||
| ADMA | ADMA BIOLOGICS INC | $17.70 | $12.71 | 39.28% | 20.11x | 19.72x | 8.64x | 9.77x | 0.85x | $40.73M | 0.97% | $431.19M | 1.81 | $4.22B | 24.54 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.09 | $19.08 | -73.32% | 3.20x | -94.43x | 727.14x | 1.61x | 0.19x | -$82.36M | -29.82% | $171.23M | 3.16 | $216.72M | 2.41 | ||
| TECH | BIO-TECHNE CORP | $66.36 | $16.26 | 308.05% | 132.72x | 32.82x | 8.48x | 5.26x | 1.81x | $224.06M | 2.17% | $1.97B | 12.65 | $10.59B | 47.94 | ||
| GMAB | GENMAB A | $33.87 | $127.88 | -73.51% | 14.46x | 1.94x | 6.10x | 3.78x | 0.11x | $1.19B | 5.49% | $5.75B | 8.96 | $20.13B | 10.06 | ||
| RPRX | ROYALTY PHARMA PLC | $40.36 | $47.16 | -14.42% | 22.93x | 7.79x | 7.42x | 2.42x | 0.40x | $2.11B | 12.11% | $9.62B | 22.28 | $31.30B | 29.98 | ||
| XOMA | XOMA ROYALTY CORP | $27.14 | $15.82 | 71.55% | 33.51x | 86.32x | 6.99x | 3.82x | 0.89x | -$12.41M | -3.77% | $87.94M | 7.25 | $377.51M | 14.11 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $188.78 | $72.23 | 161.37% | 81.72x | 22.43x | 14.71x | 3.91x | 1.17x | $30.76M | 0.83% | $950.17M | 48.53 | $4.03B | 39.09 | ||
| CRMD | CORMEDIX INC | $7.06 | $17.80 | -60.34% | 3.11x | 2.80x | 2.50x | 1.49x | 0.54x | $74.42M | 13.88% | $374.13M | 4.93 | $656.68M | 5.85 | ||
| MNKD | MANNKIND CORP | $5.64 | $2.78 | 103.13% | 56.40x | 51.41x | 5.51x | -38.87x | 0.94x | $43.39M | 2.50% | -$44.55M | -0.15 | $1.96B | 26.84 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.50 | $4.32 | 50.60% | 24.07x | 21.60x | 4.16x | 7.34x | 0.86x | $21.15M | 4.08% | $70.68M | 0.89 | $457.50M | 20.16 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.99 | $9.83 | 52.48% | 25.84x | 15.72x | 7.43x | 5.40x | 0.84x | $119.87M | 6.06% | $365.77M | 2.78 | $1.98B | 19.14 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.76 | $61.16 | -41.53% | 11.07x | 8.46x | 2.49x | 2.47x | 0.31x | $296.89M | 14.43% | $835.12M | 14.51 | $1.58B | 5.86 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $454.67 | $190.20 | 139.05% | 31.77x | 22.23x | 9.91x | 6.66x | 1.54x | $3.34B | 2.87% | $17.32B | 67.76 | $112.25B | 24.08 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.02 | $3.57 | -43.38% | 28.86x | 11.43x | 2.59x | 3.07x | 0.23x | -$11.69M | -7.28% | $52.91M | 0.67 | $156.98M | 17.70 | ||
| VCYT | VERACYTE INC | $43.05 | $12.31 | 249.68% | 110.38x | 40.92x | 6.85x | 2.71x | 1.56x | $98.21M | 2.90% | $1.26B | 15.98 | $3.13B | 54.85 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.20 | $51.34 | 7.51% | 20.29x | 12.25x | 3.43x | 1.75x | 0.57x | $832.13M | 7.85% | $6.06B | 31.54 | $9.95B | 12.88 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $21.33 | $6.67 | 219.84% | 60.94x | -19.21x | 2.65x | 6.73x | 1.68x | $78.64M | 2.92% | $401.17M | 3.17 | $2.69B | 28.85 | ||
| EXEL | EXELIXIS INC | $44.08 | $36.52 | 20.69% | 17.92x | 13.95x | 5.17x | 5.47x | 0.72x | $779.77M | 6.59% | $2.16B | 8.05 | $11.62B | 12.53 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.67 | $80.68 | -11.17% | 14.66x | 8.64x | 6.76x | 16.73x | 0.50x | $602.40M | 7.17% | $503.92M | 4.30 | $9.52B | 11.26 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $22.35 | $22.61 | -1.16% | 12.49x | 11.46x | 4.74x | 2.99x | 0.66x | $234.54M | 8.56% | $920.25M | 7.51 | $2.06B | 6.36 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $758.91 | $412.12 | 84.15% | 17.47x | 16.48x | 5.52x | 2.58x | 1.71x | $4.22B | 5.37% | $30.96B | 298.82 | $79.96B | 14.00 | ||
| MDXG | MIMEDX GROUP INC | $5.88 | $5.05 | 16.36% | 21.00x | 23.53x | 2.21x | 3.64x | 0.62x | $66.82M | 7.67% | $238.95M | 1.61 | $746.97M | 10.79 | ||
| INVA | INNOVIVA INC | $19.51 | $19.37 | 0.74% | 10.32x | 8.93x | 3.47x | 1.44x | 0.84x | $196.54M | 14.59% | $1.01B | 14.63 | $1.24B | 5.77 | ||
| UTHR | UNITED THERAPEUTICS CORP | $476.86 | $251.10 | 89.91% | 16.74x | 16.03x | 6.68x | 3.12x | 1.99x | $1.12B | 5.37% | $6.59B | 150.46 | $19.19B | 10.82 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $26.46 | $12.34 | 114.37% | 16.85x | 32.86x | 4.27x | 4.88x | 2.91x | $197.81M | 4.43% | $917.27M | 5.43 | $4.25B | 14.78 | ||
| INCY | INCYTE CORP | $103.43 | $77.27 | 33.86% | 17.12x | 12.85x | 4.20x | 4.37x | 0.89x | $1.20B | 5.92% | $4.65B | 23.77 | $17.88B | 10.63 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.